US government health officials on Monday (US time) approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow...
Full ArticleFDA approves much-debated Alzheimer's drug panned by experts
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
How the new Alzheimer’s disease drug could influence future research
Upworthy
The FDA’s controversial approval of a Biogen drug for Alzheimer’s disease could blunt future R&D, experts warn.
-
Stocks end mixed but Nasdaq powers to another record close
Proactive Investors
-
US stocks mixed at mid-session as traders get cautious on risk
Proactive Investors
-
Wall Street rises at the opening bell
Proactive Investors
-
Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited
NYTimes.com
Advertisement
More coverage
FDA officials asked to step down after contentious Alzheimer’s drug approval
Ars Technica
Three experts resigned in protest. Watchdog says it's FDA brass that should leave.
-
FDA officials should resign over 'reckless' approval of Biogen Alzheimer’s drug, says US consumer rights group
Proactive Investors
-
First patient set to receive controversial Biogen Alzheimer' s drug
MENAFN.com
-
Three experts resign as FDA advisors over approval of Alzheimer’s drug
Ars Technica
-
New Controversial Alzheimer's Drug Provides Hope, Says Patient
NPR